Mon, Nov 16, 2026 - Page 46
8174 indexed SquawkNews stories from this UTC day. Showing 5401-5520.
L
GXO LOGISTICS - SETS 2030 TARGETS: >7% ORGANIC REVENUE CAGR, >6.5% ADJ EBITA MARGIN, 40%-50% FREE CASH FLOW CONVERSION
GXO LOGISTICS - SETS 2030 TARGETS: >7% ORGANIC REVENUE CAGR, >6.5% ADJ EBITA MARGIN, 40%-50% FREE CA
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Duke Robotics Reports Third Quarter 2026 Financial Results and Provides Business Update
Commercial Expansion of IC Drone Platform into Greece Through Strategic Collaboration with CRONOS; P
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Cypherpunk Technologies Reports Third Quarter 2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC Mined in 44 days, representing $9.9 million revenue at a
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
HSBC Raises Entergy Price Target to $127.50 From $123.50
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Rep
Participants in high-dose cohorts achieved 80% mean reduction in non-sustained ventricular tachycard
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
DALLAS, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc.
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Prime Builder Conditionally Agrees to Sell Engineering Unit
Prime Builder Limited conditionally agreed to sell the entire share capital of Prime Builder Engineering.
MNA | Nov 16, 2026, 12:01 PM UTC
L
Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
Board reiterates commitment to improving performance and maximizing stockholder value; has been actively involved in a comprehensive review of a broad range of strategic, operational, and financial alternatives.BELGRADE,
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
GOLDEN WHEAT MILLS Q3 REVENUE JOD 4.7 MLN
GOLDEN WHEAT MILLS Q3 REVENUE JOD 4.7 MLN
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Warren Buffett to Convert 6,150 Berkshire Class A Shares Into 9,225,000 Class B Shares
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Eloxx Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
ARLINGTON, Mass., Nov. 16, 2026 // -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases, today reported financial results
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Buffett to Own 182,140 Berkshire Class A Shares and 1,162 Class B Shares After Donations
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Sasquatch Resources Completes Acquisition of Echo Property
MNA | Nov 16, 2026, 12:01 PM UTC
L
Duke Robotics 3Q Loss/Shr 24c >DUKR
Duke Robotics 3Q Loss/Shr 24c >DUKR
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Creative Media & Comm 3Q Loss/Shr $6.29 >CMCT
Creative Media & Comm 3Q Loss/Shr $6.29 >CMCT
EQUITY | Nov 16, 2026, 12:01 PM UTC
M
Macerich to Fund Acquisition With 11 Million Shares at $23.12 Each
Macerich will fund an acquisition with 11 million shares priced at $23.12 per share.
MNA | Nov 16, 2026, 12:01 PM UTC
L
TempraMed Signs Exclusive Distribution Agreement with DayMed Qatar
TempraMed signed an exclusive distribution agreement with DayMed Qatar, expanding its commercial footprint in the Gulf region.
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Rubicon Organics Reports Q3 2026 Financial Results
Q3 2026 net revenue of $18.3 million and year-to-date net revenue of $50.4 million, both up 17% year
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Gemspring Capital Closes Fourth Buyout Fund at $3.5 Billion Hard Cap
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Rubicon Organics Q3 Revenue CAD 18.3 Million
Nov 16 (Reuters) - Rubicon Organics Q3 adjusted EBITDA CAD 1.4 million.
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
GOLDEN WHEAT MILLS Q3 PROFIT ATTRIBUTABLE JOD 352,933
GOLDEN WHEAT MILLS Q3 PROFIT ATTRIBUTABLE JOD 352,933
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Instil Bio Q3 Basic EPS USD -0.62
Nov 16 (Reuters) - Instil Bio Q3 operating expenses USD 5.985 million.
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Selkirk Copper Completes Phase 2 Drill Program Comprising 54,579 Metres in 223 Drill Holes and Reports Additional High-Grade Results from Fo
Selkirk Copper Completes Phase 2 Drill Program Comprising 54,579 Metres in 223 Drill Holes and Repor
COMMODITIES | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Xtant Medical Q3 Revenue USD 24.3 Million
Nov 16 (Reuters) - Xtant Medical Q3 net income USD -3.6 million.
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Eloxx Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Dosed first two patients in global Phase 2b EXACT study of exaluren in nonsense mutation Alport synd
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.44
Nov 16 (Reuters) - Cypherpunk Technologies Inc Q3 operating income USD 2.606 million.
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
BRIEF-POET Technologies Q3 EPS USD -0.04
Nov 16 (Reuters) - POET Technologies Q3 net income USD -7.6 million.
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlook
Completes BitSink Acquisition and Sharpens Commercial Focus on Highest-Value Applications for AirJou
MNA | Nov 16, 2026, 12:01 PM UTC
H
Western Midstream Announces Third-Quarter Post-Earnings Interview with Chief Financial Officer, Kristen Shults and Participation in Upcoming
HOUSTON, Nov. 16, 2026 /PRNewswire/ -- Today Western Midstream Partners, LP (NYSE: WES) ("WES" or th
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Broadridge Launches Oracle for Tokenized-Shareholder Communications
Broadridge and Coinbase published a proposed open standard for delivering shareholder communications to wallets holding tokenized shares and submitted it as an Ethereum Improvement Proposal. Broadridge also launched a da
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Cypherpunk Technologies Reports Third Quarter 2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC Mined in 44 days, representing $9.9 million revenue at a
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
Prelude Therapeutics 3Q Loss/Shr 12c >PRLD
Prelude Therapeutics 3Q Loss/Shr 12c >PRLD
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
GT Biopharma Reports Third Quarter 2026 Financial Results
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phas
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
Board reiterates commitment to improving performance and maximizing stockholder value; has been acti
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
Prelude Therapeutics 3Q Loss $12.5M >PRLD
Prelude Therapeutics 3Q Loss $12.5M >PRLD
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
CYPHERPUNK TECHNOLOGIES INC Q3 OPERATING INCOME USD 2.606 MILLION
CYPHERPUNK TECHNOLOGIES INC Q3 OPERATING INCOME USD 2.606 MILLION
FX | Nov 16, 2026, 12:01 PM UTC
L
Duke Robotics 3Q Rev $299,000 >DUKR
Duke Robotics 3Q Rev $299,000 >DUKR
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
CREATIVE MEDIA & COMMUNITY TRUST CORP Q3 EPS USD -6.29
CREATIVE MEDIA & COMMUNITY TRUST CORP Q3 EPS USD -6.29
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
CYPHERPUNK TECHNOLOGIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
CYPHERPUNK TECHNOLOGIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
CREATIVE MEDIA & COMMUNITY TRUST CORP Q3 NET INCOME USD -18.167 MILLION
CREATIVE MEDIA & COMMUNITY TRUST CORP Q3 NET INCOME USD -18.167 MILLION
FX | Nov 16, 2026, 12:01 PM UTC
L
XTANT MEDICAL Q3 REVENUE USD 24.3 MILLION
XTANT MEDICAL Q3 REVENUE USD 24.3 MILLION
EARNINGS | Nov 16, 2026, 12:01 PM UTC
H
Ukraine's Military: Struck Russia's Ilsky Oil Refinery
Ukraine's Military: Struck Russia's Ilsky Oil Refinery
COMMODITIES | Nov 16, 2026, 12:01 PM UTC
L
HELUS PHARMA ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 APPROACH STUDY EVALUATING HLP003 AS ADJUNCTIVE TREATMENT IN MAJOR DEPRESSIVE DI
HELUS PHARMA ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 APPROACH STUDY EVALUATING HLP003 AS ADJ
EQUITY | Nov 16, 2026, 12:01 PM UTC
L
RUBICON ORGANICS Q3 REVENUE CAD 18.3 MILLION
RUBICON ORGANICS Q3 REVENUE CAD 18.3 MILLION
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
XTANT MEDICAL Q3 EPS USD -0.03
XTANT MEDICAL Q3 EPS USD -0.03
EARNINGS | Nov 16, 2026, 12:01 PM UTC
L
RUBICON ORGANICS REPORTS Q3 2026 FINANCIAL RESULTS
RUBICON ORGANICS REPORTS Q3 2026 FINANCIAL RESULTS
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Pomerantz LLP Advises NVIDIA Shareholders About Class Action
Pomerantz LLP issued an advisory to NVIDIA shareholders concerning a class action. The supplied report provides no further details.
EQUITY | Nov 16, 2026, 12:00 PM UTC
M
Church & Dwight to Acquire 45% Stake in BALI Treatment for $225 Million
Church & Dwight signed a definitive agreement to acquire 45% of BALI Treatment GmbH for approximately $225 million. BALI Treatment owns the BALI CURLS and BALI GENTS brands.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
GT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
GT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Church & Dwight Announces Investment in Bali Curls and Bali Gents
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
ELOXX PHARMACEUTICALS Q3 INCOME FROM OPERATIONS USD -5.953 MILLION
ELOXX PHARMACEUTICALS Q3 INCOME FROM OPERATIONS USD -5.953 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
ELOXX PHARMACEUTICALS Q3 BASIC EPS USD -0.49
ELOXX PHARMACEUTICALS Q3 BASIC EPS USD -0.49
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
AIRJOULE TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES PRELIMINARY 2027 BITSINK OUTLOOK
AIRJOULE TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES PRELIMINARY 2027 BITSINK OUTLO
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
INSTIL BIO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
INSTIL BIO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Di
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adj
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Rubicon Organics Reports Q3 2026 Financial Results
Rubicon Organics Reports Q3 2026 Financial Results Q3 2026 net revenue of $18.3 million and year-to
EARNINGS | Nov 16, 2026, 12:00 PM UTC
M
Cypherpunk Technologies Reports $306.0M Q3 Net Income
Cypherpunk Technologies reported Q3 net income of $306.0 million, versus a $3.3 million loss a year earlier. The result was primarily driven by a non-cash $330.8 million unrealized gain on an embedded derivative; first-p
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Pomerantz Reminds Bank of America Investors of Class Action Lawsuit
Pomerantz LLP issued a reminder to investors in Bank of America Corporation regarding a class action lawsuit.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Creative Media & Comm 3Q Rev $27.4M >CMCT
Creative Media & Comm 3Q Rev $27.4M >CMCT
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
ELOXX PHARMACEUTICALS Q3 NET INCOME USD -5.543 MILLION
ELOXX PHARMACEUTICALS Q3 NET INCOME USD -5.543 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
INSTIL BIO Q3 OPERATING INCOME USD -5.985 MILLION
INSTIL BIO Q3 OPERATING INCOME USD -5.985 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
CYPHERPUNK TECHNOLOGIES INC Q3 NET INCOME USD 306.005 MILLION
CYPHERPUNK TECHNOLOGIES INC Q3 NET INCOME USD 306.005 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
POET Technologies Reports Record Q3 2026 Revenue of $1.03M, Up 244%
POET Technologies Reports Record Q3 2026 Revenue of $1.03M, Up 244% TORONTO, Nov. 16, 2026 (GLOBE NE
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Creative Media & Community Trust Corporation Reports 2026 Third Quarter Results
Creative Media & Community Trust Corporation (NASDAQ:CMCT) (“we”, “our”, “CMCT”, or the “Company”) today reported operating results for the three months ended September 30, 2026.On March 26, 2026, the Company effected a
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
XTANT MEDICAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES BOARD-LED STRATEGIC REVIEW PROCESS
XTANT MEDICAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES BOARD-LED STRATEGIC REVIEW
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Coinbase and Broadridge Publish Proposed Onchain Shareholder Communications Standard
The proposed standard connects wallet-based communications with verifiable evidence; Broadridge also launches a data oracle.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
INSTIL BIO Q3 BASIC EPS USD -0.62
INSTIL BIO Q3 BASIC EPS USD -0.62
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
CYPHERPUNK TECHNOLOGIES INC Q3 EPS USD 1.44
CYPHERPUNK TECHNOLOGIES INC Q3 EPS USD 1.44
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
XTANT MEDICAL Q3 NET INCOME USD -3.6 MILLION
XTANT MEDICAL Q3 NET INCOME USD -3.6 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
Creative Media & Community Trust Corporation Reports 2026 Third Quarter Results
LOS ANGELES--(BUSINESS WIRE)-- Creative Media & Community Trust Corporation (NASDAQ: CMCT) (“we”, “o
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Buffett to Donate 9.225 Million Berkshire Hathaway Class B Shares
Warren E. Buffett will convert 6,150 Class A shares into 9,225,000 Class B shares and donate them to four family foundations. Afterward, he will own 182,140 Class A shares and 1,162 Class B shares.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
POET TECHNOLOGIES Q3 NET INCOME USD -7.6 MILLION
POET TECHNOLOGIES Q3 NET INCOME USD -7.6 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
POET TECHNOLOGIES Q3 EPS USD -0.04
POET TECHNOLOGIES Q3 EPS USD -0.04
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Great Public Schools New York Launches Ahead of Legislative Session
The organization launched ahead of New York’s 2027 legislative session to advocate for public charter schools. The supplied body says 57% support expanding charter schools in New York and 18% oppose.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Rep
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PK
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Di
HLP003 achieved statistically significant and clinically meaningful results in the primary and key s
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Duke Robotics Reports Third Quarter 2026 Financial Results and Provides Business Update
Duke Robotics Reports Third Quarter 2026 Financial Results and Provides Business Update Commercial E
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
GT BIOPHARMA Q3 NET INCOME USD -3.5 MILLION
GT BIOPHARMA Q3 NET INCOME USD -3.5 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
INSTIL BIO Q3 NET INCOME USD -4.231 MILLION
INSTIL BIO Q3 NET INCOME USD -4.231 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PKP2 ARRHYTHMOGENIC CARDIOMYOPATHY AND REP
LEXEO THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE I/II DATA AND REGULATORY UPDATE FOR LX2020 IN PK
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
/R E P E A T -- METRO Inc. to Release 2026 Fourth Quarter Results/
MONTREAL, Oct. 6, 2026 /CNW/ -- METRO Inc.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
DUKE ROBOTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
DUKE ROBOTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Cypherpunk Technologies Reports Third Quarter 2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC Mined in 44 days, representing $9.9 million revenueat approximately $104 cost of mining revenue per ZEC and 95% uptimeTreasury increased to 341,858.75 ZEC, including October mi
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
RUBICON ORGANICS Q3 ADJUSTED EBITDA CAD 1.4 MILLION
RUBICON ORGANICS Q3 ADJUSTED EBITDA CAD 1.4 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
M
T. Rowe Price OHA Fund Reports Q3 Results, Declares $0.60 Per Share
T. Rowe Price OHA Select Private Credit Fund reported results for the quarter ended September 30, 2026, and declared total distributions of $0.60 per share.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
CREATIVE MEDIA & COMMUNITY TRUST CORPORATION REPORTS 2026 THIRD QUARTER RESULTS
CREATIVE MEDIA & COMMUNITY TRUST CORPORATION REPORTS 2026 THIRD QUARTER RESULTS
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
GT Biopharma Reports Third Quarter 2026 Financial Results
GT Biopharma Reports Third Quarter 2026 Financial Results Phase 1 trial evaluating GTB-3650 TriKE® r
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
AIRJOULE TECHNOLOGIES Q3 BASIC EPS USD -0.27
AIRJOULE TECHNOLOGIES Q3 BASIC EPS USD -0.27
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results VANCO
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
POET TECHNOLOGIES REPORTS RECORD Q3 2026 REVENUE OF $1.03M, UP 244%
POET TECHNOLOGIES REPORTS RECORD Q3 2026 REVENUE OF $1.03M, UP 244%
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Coinbase and Broadridge Publish Proposed Onchain Shareholder Communications Standard
Coinbase and Broadridge published a proposed standard for onchain shareholder communications. Broadridge also launched a data oracle.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Buffett to Convert Berkshire A Shares and Donate B Shares
Warren Buffett plans to convert 6,150 Berkshire Class A shares into 9,225,000 Class B shares and donate them to four family foundations. The supplied release text is truncated before naming all recipients.
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Cypherpunk Technologies Reports Third Quarter 2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC Mined in 44 days, representing $9.9 million revenue at a
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
Western Midstream Announces Third-Quarter Post-Earnings Interview with Chief Financial Officer, Kristen Shults and Participation in Upcoming
HOUSTON, Nov. 16, 2026 // -- Today Western Midstream Partners, LP (NYSE:WES) ("WES" or the "Partnership") announced that tomorrow before the market open it will make available on its website at a post-earnings interview
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
GT BIOPHARMA Q3 INCOME FROM OPERATIONS USD -3.5 MILLION
GT BIOPHARMA Q3 INCOME FROM OPERATIONS USD -3.5 MILLION
FX | Nov 16, 2026, 12:00 PM UTC
L
Datasection 1H Loss Y2.35B Vs Loss Y1.47B
Datasection 1H Loss Y2.35B Vs Loss Y1.47B
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Eloxx Pharmaceuticals 3Q Loss/Shr 49c >ELOX
Eloxx Pharmaceuticals 3Q Loss/Shr 49c >ELOX
EQUITY | Nov 16, 2026, 12:00 PM UTC
H
SONM Q3'26 Earnings: EPS estimate is 5.04 USD
SONM (DNA X, Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 36.06 million USD with EPS
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlook
AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlo
EQUITY | Nov 16, 2026, 12:00 PM UTC
H
FBLG Q3'26 Earnings: EPS estimate is (0.63) USD
FBLG (FibroBiologics, Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (e
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Eloxx Pharmaceuticals 3Q Loss $5.54M >ELOX
Eloxx Pharmaceuticals 3Q Loss $5.54M >ELOX
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Xtant Medical Holdings 3Q Loss $3.56M >XTNT
Xtant Medical Holdings 3Q Loss $3.56M >XTNT
EQUITY | Nov 16, 2026, 12:00 PM UTC
M
ABEN GOLD REPORTS FIRST ASSAY RESULTS FROM THE 2026 DRILL PROGRAM
ABEN GOLD REPORTS FIRST ASSAY RESULTS FROM THE 2026 DRILL PROGRAM
COMMODITIES | Nov 16, 2026, 12:00 PM UTC
L
Datasection Sees FY Loss Y1.48B
Datasection Sees FY Loss Y1.48B
EQUITY | Nov 16, 2026, 12:00 PM UTC
L
Xtant Medical Holdings 3Q Rev $24.3M >XTNT
Xtant Medical Holdings 3Q Rev $24.3M >XTNT
EQUITY | Nov 16, 2026, 12:00 PM UTC
H
TCRT Q3'26 Earnings: EPS estimate is (2.05) USD
TCRT (Alaunos Therapeutics, Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, EPS (earnings per share) is ant
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
SURG Q3'26 Earnings: EPS estimate is (0.07) USD
SURG (SurgePays, Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 16.50 million USD with
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Xtant Medical Holdings 3Q Loss/Shr 3c >XTNT
Xtant Medical Holdings 3Q Loss/Shr 3c >XTNT
EQUITY | Nov 16, 2026, 12:00 PM UTC
M
Aben Gold Reports First Assay Results from the 2026 Drill Program
Aben Gold Reports First Assay Results from the 2026 Drill Program Vancouver, BC, Nov. 16, 2026 (GLOB
COMMODITIES | Nov 16, 2026, 12:00 PM UTC
L
Pomerantz Notifies Alphabet Shareholders of Class Action Lawsuit
Pomerantz LLP notified Alphabet shareholders of a class action lawsuit against the company.
REGULATION | Nov 16, 2026, 12:00 PM UTC
H
JAGX Q3'26 Earnings: EPS estimate is (444.29) USD
JAGX (Jaguar Health, Inc.) is set to announce its Q3'26 results on November 17, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 4.85 million U
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
PPSI Q3'26 Earnings: EPS estimate is (0.12) USD
PPSI (Pioneer Power Solutions, Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 6.57 mil
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Faeth Therapeutics Announces Trial Collaboration and Supply Agreement With Roche
The companies will evaluate PIKTOR with a selective estrogen receptor degrader in HR+/HER2- advanced breast cancer.
EQUITY | Nov 16, 2026, 12:00 PM UTC
H
IRIX Q3'26 Earnings: EPS estimate is (0.04) USD
IRIX (IRIDEX Corporation) is set to announce its Q3'26 results on November 17, after the market closes. The earnings are expected to be disclosed at 4:05 PM ET (9:05 PM UTC).For Q3'26, revenue estimate is 12.64 million U
EARNINGS | Nov 16, 2026, 12:00 PM UTC
L
Zoox Robotaxis Now Available Through Uber in Las Vegas
Riders can be matched with Zoox autonomous robotaxis through the Uber app in Las Vegas.
EQUITY | Nov 16, 2026, 12:00 PM UTC
H
COSM Q3'26 Earnings: EPS estimate is (0.80) USD
COSM (Cosmos Health Inc.) is set to announce its Q3'26 results on November 17, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 17.34 million USD w
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
NRXP Q3'26 Earnings: EPS estimate is (0.21) USD
NRXP (NRX Pharmaceuticals, Inc.) is set to announce its Q3'26 results on November 17, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 1.29 mil
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
ONEW Q4'26 Earnings: EPS estimate is 0.05 USD
ONEW (OneWater Marine Inc.) is set to announce its Q4'26 results on November 17, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q4'26, revenue estimate is 429.03 millio
EARNINGS | Nov 16, 2026, 12:00 PM UTC
H
ESEA Q3'26 Earnings: EPS estimate is 4.99 USD
ESEA (Euroseas Ltd.) is set to announce its Q3'26 results on November 17, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 56.82 million USD wi
EARNINGS | Nov 16, 2026, 12:00 PM UTC